Company Overview and News

 
DoE sees over 8,600 MW of new capacity by 2025

2018-03-15 bworldonline
THE Energy department expects 8,618.36 megawatts (MW) of power generating capacity to be added to the power grid between January 2018 and the end of 2025, majority of which will come from coal-fired power plants.

 
PHL under pressure to diversify energy sources — BMI

2018-03-06 bworldonline
DWINDLING supply from the Malampaya gas field and dormant exploration activity will make the Philippines more reliant on imports, BMI Research, a Fitch unit, said in a report.

 
Philippines' $2B LNG Project Draws Interest From Tokyo Gas, Three Others

2018-03-01 rigzone
MANILA, March 1 (Reuters) - There are at least four potential investors for the Philippine government's planned liquefied natural gas (LNG) import facility, including Tokyo Gas Co Ltd, a government energy official said on Thursday.

 
Philippines' $2 Bln LNG Project Draws Interest From Tokyo Gas, Three Others

2018-03-01 rigzone
MANILA, March 1 (Reuters) - There are at least four potential investors for the Philippine government's planned liquefied natural gas (LNG) import facility, including Tokyo Gas Co Ltd, a government energy official said on Thursday.

2
PNOC receives more offers for $2-B LNG terminal project

2018-01-04 philstar
MANILA, Philippines — New offers were submitted by First Gen Corp., Energy World Corp., PT. Jaya Samudra Karunia, and PT PGN LNG Indonesia/PT Bosowa Corporindo with their local partner MOF Corp., PNOC spokesperson Ryan Tanjutco said.

 
Oil & Gas Stock Roundup: Shell Boosts Power Market Presence, Cabot Sells Eagle Ford Assets

2017-12-27 zacks
It was a week where both oil and natural gas prices experienced noticeable upticks on healthy storage draws. On the news front, supermajor Royal Dutch Shell plc (RDS.A - Free Report) has signed an agreement to purchase British energy supplier First Utility, while domestic natural gas producer Cabot Oil & Gas Corporation (COG - Free Report) announced plans to offload its Eagle Ford shale holdings for $765 million.

 
Oil & Gas Stock Roundup: MDR-CBI Tie-Up, STO's Oilfield Stake Buy & More

2017-12-19 zacks
It was a week where oil prices remained essentially unchanged but natural gas futures sunk to multi-month lows. On the news front, energy-focused construction and engineering companies McDermott International Inc. (MDR - Free Report) and Chicago Bridge & Iron Company N.V. (CBI - Free Report) agreed to merge in a $6 billion deal, while Norway’s Statoil ASA (STO - Free Report) bought a 25% interest in a large Brazilian oilfield from Petrobras (PBR - Free Report) for up to $2.

 
Zamora, Chinese partner to build LNG-fired power plant

2017-10-29 philstar
MANILA, Philippines — Businessman Salvador “Buddy” Zamora II, together with a Chinese partner, is building a 1.1-gigawatt LNG-fired power plant in Zambales, a project that seeks to help address the country’s energy security.

 
Strike Energy signs gas supply deal for its Southern Cooper Basin Gas Project

2017-09-25 proactiveinvestors.com.au
Strike Energy Ltd (ASX:STX) has executed a new gas sales agreement with Orica International Pte Ltd for the supply of up to 64 petajoules of gas from Strike’s Southern Cooper Basin Gas Project.

 
Strike Energy signs gas supply deal for its Southern Cooper Basin Gas Project

2017-09-24 proactiveinvestors.com.au
Strike Energy Ltd (ASX:STX) has executed a new gas sales agreement with Orica International Pte Ltd for the supply of up to 64 petajoules of gas from Strike’s Southern Cooper Basin Gas Project.

 
Fourchon LNG kicks off federal regulatory process for $888-million LNG facility

2017-08-11 worldoil
CUT OFF, Louisiana -- The Greater Lafourche Port Commission (GLPC) and tenant Energy World USA (EWUSA) have announced that wholly-owned Fourchon LNG LLC has filed its formal letter to request initiation of the pre-filing review process with the U.S. Federal Energy Regulatory Commission (FERC). Upon completion of the pre-filing process, Fourchon LNG LLC intends to file an application with FERC for authorization to construct the proposed 5 million tons per annum mid-scale liquefied natural gas (LNG) production and export facility at Port Fourchon.

 
Chinese Wind Power Giant Wants to Be App Store of Energy World - Bloomberg

2017-07-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

 
Company plans $800 million LNG plant at Port Fourchon

2017-02-02 nzherald.co.nz
GALLIANO, La. (AP) " Officials are planning an $800 million liquefied natural gas plant and export terminal at Port Fourchon.

 
Louisiana's Port Fourchon May Add LNG Tenant

2017-02-01 rigzone
Many Gulf of Mexico oil and gas workers know Port Fourchon as a Louisiana land base where offshore hitches begin and end. The intermodal transportation hub, operated by the Greater Lafourche Port Commission (GLPC), could also become home to a mid-scale liquefied natural gas (LNG) production and export facility.

 
DOE rolls out plan for LNG terminal

2016-09-13 philstar
MANILA, Philippines – The Departmenty of Energy plans to spearhead the establishment of a liquified natural gas (LNG) terminal, whether the Malampaya deep water gas-to-power project gets extended or not, to ensure continued supply in the country.

Related Articles

HRTX : Heron Therapeutics Analysis and Research Report

2018-05-25 - Asif

Overview Heron is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments that address some of the most important unmet patient needs. Heron Therapeutics is developing novel, patient-focused solutions that apply its innovative science and technologies to already approved pharmacological agents for patients suffering from cancer or pain. On August 9, 2016, its first commercial product, SUSTOL, was approved by the FDA. The company developed SUSTOL for the prevention of chemotherapy-induced nausea and vomiting (“CINV”). SUSTOL is indicated, in combination with other antiemetics, in adults for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic chemotherapy (“MEC”) or anthracycline and cyclophosphamide (“AC”) combination chemotherapy regimens. The company commenced commercial sales of SUSTOL in the U.S. in October 2016. On November 9, 2017...

ACIA: Acacia Communications Analysis and Research Report

2018-05-25 - Asif

Overview The company's mission is to deliver high-speed coherent optical interconnect products that transform communications networks, relied upon by cloud infrastructure operators and content and communication service providers, through improvements in performance and capacity and reductions in associated costs. By converting optical interconnect technology to a silicon-based technology, a process the company refer to as the siliconization of optical interconnect, the company believe Acacia Communications is leading a disruption that is analogous to the computing industry’s integration of multiple functions into a microprocessor. The company's products include a family of low-power coherent digital signal processor application-specific integrated circuits, or DSP ASICs, and silicon photonic integrated circuits, or silicon PICs, which Acacia Communications has integrated into families of optical interconnect modules with transmission speeds ranging from 100 to 400 gigabits per ...

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...